Data demonstrate that uPARAP is highly expressed in tumor samples obtained from glioblastoma multiforme patientsuPARAP targeting ADC shows cytotoxicity in glioblastoma multiforme cancer cells in vitro and exhibits potent in vivo anti-tumor activity in a glioblastoma multiforme PDX modelData provides evidence that uP.
/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of first-in-class antibody-drug conjugates (ADCs) for the treatment of.